Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirin Kalimuddin

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Medrxiv : the Preprint Server for Health Sciences|June 8, 2021
Signatures of mast cell activation are associated with severe COVID-19Janessa Tan, Danielle E Anderson, Abhay P S Rathore, et al.
Trials|July 19, 2022
Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trialI Russel Lee, Steven Y C Tong, Joshua S Davis, et al.
The Journal of Clinical Investigation|August 10, 2023
Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19Janessa Yj Tan, Danielle E Anderson, Abhay Ps Rathore, et al.
Nature|July 16, 2020
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controlsNina Le Bert, Anthony T Tan, Kamini Kunasegaran, et al.
Vaccine|June 18, 2024
Proceedings of the dengue endgame summit: Imagining a world with dengue controlAdam D Wegman, Shirin Kalimuddin, Ernesto T A Marques, et al.
NPJ Vaccines|November 28, 2022
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccineEugenia Z Ong, Jia Xin Yee, Justin S G Ooi, et al.
Plos Biology|May 31, 2022
Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genesAyesa Syenina, Esther S Gan, Justin Z N Toh, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2021
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort studyPo Ying Chia, Sean Wei Xiang Ong, Calvin J Chiew, et al.
NPJ Vaccines|December 13, 2022
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccineJenny G Low, Ruklanthi de Alwis, Shiwei Chen, et al.
Singapore Medical Journal|October 13, 2020
Radiographic features of COVID-19 based on an initial cohort of 96 patients in SingaporeHau Wei Wei Khoo, Terrence Chi Hong Hui, Salahudeen Mohamed Haja Mohideen, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Medrxiv : the Preprint Server for Health Sciences|June 8, 2021
Signatures of mast cell activation are associated with severe COVID-19Janessa Tan, Danielle E Anderson, Abhay P S Rathore, et al.
Trials|July 19, 2022
Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trialI Russel Lee, Steven Y C Tong, Joshua S Davis, et al.
The Journal of Clinical Investigation|August 10, 2023
Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19Janessa Yj Tan, Danielle E Anderson, Abhay Ps Rathore, et al.
Nature|July 16, 2020
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controlsNina Le Bert, Anthony T Tan, Kamini Kunasegaran, et al.
Vaccine|June 18, 2024
Proceedings of the dengue endgame summit: Imagining a world with dengue controlAdam D Wegman, Shirin Kalimuddin, Ernesto T A Marques, et al.
NPJ Vaccines|November 28, 2022
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccineEugenia Z Ong, Jia Xin Yee, Justin S G Ooi, et al.
Plos Biology|May 31, 2022
Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genesAyesa Syenina, Esther S Gan, Justin Z N Toh, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2021
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort studyPo Ying Chia, Sean Wei Xiang Ong, Calvin J Chiew, et al.
NPJ Vaccines|December 13, 2022
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccineJenny G Low, Ruklanthi de Alwis, Shiwei Chen, et al.
Singapore Medical Journal|October 13, 2020
Radiographic features of COVID-19 based on an initial cohort of 96 patients in SingaporeHau Wei Wei Khoo, Terrence Chi Hong Hui, Salahudeen Mohamed Haja Mohideen, et al.
Pageof 10